BackPrince Pharmaceutical , Ltd. Overview

Prince Pharmaceutical , Ltd. Long Term Debt

Track Prince Pharmaceutical , Ltd.'s long-term debt ($340M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$338.96M
↓ 8.64% YoYΔ $-32.04M vs prior year quarter

Peer trimmed avg / median

Loading

Prince Pharmaceutical , Ltd. Long Term Debt History

Loading

Prince Pharmaceutical , Ltd. vs. peers: Long Term Debt Comparison

Loading

Prince Pharmaceutical , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Prince Pharmaceutical , Ltd. (6935.TWO) FAQ

As of the most recent data (June 2026), 6935.TWO shows a long-term debt of $340M. That compares with $370M in the prior-year period — down 8.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6935.TWO's long-term debt is now $340M (was $370M) — a 8.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Prince Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 6935.TWO's long-term debt over time shows whether Prince Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $340M That compares with $370M in the prior-year period — down 8.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Prince Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $340M) with ownership activity and broader fundamentals.